Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Welfide describes new research in the area of cytokine modulation

May 30, 2001

Inhibitors of IL-6 production particularly useful in inflammatory diseases

May 29, 2001

Cytokine-inhibitory pyrimidines under evaluation at AstraZeneca

May 28, 2001

Imidazole-based cytokine inhibitors designed at Merck & Co.

May 21, 2001

U.S. Army to test CT-3 in vivo

May 21, 2001

Small molecules from Genentech inhibit interaction between alpha4 integrins and their ligands

May 16, 2001

Humanized antibody safe and effective in phase I/II studies in RA patients

May 16, 2001

Long-term safety and efficacy of adalimumab demonstrated in active RA

May 16, 2001

Active metabolite of leflunomide proven to suppress eotaxin production

May 15, 2001

KS Biomedix moves KSB-302 into phase IIb for RA

May 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...